Management of Hidradenitis Suppurativa in the United Arab Emirates (UAE): A Consensus Statement from the Emirates Dermatology Society
Abstract
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting the pilosebaceous unit and is linked to several comorbid disorders as well as an economic impact burden. Variations in clinical presentation, comorbidities and healthcare delivery across regions necessitate localised guidelines. This consensus aims to provide evidence-based, expert-driven recommendations tailored to the United Arab Emirates (UAE) healthcare context to standardise and improve HS management.
Methods: A three-phase modified Delphi methodology was employed to develop consensus statements among 14 experts based in the UAE. A comprehensive literature review informed the development of 61 draft statements covering diagnosis, classification, comorbidities, treatment and multidisciplinary care. Statements achieving ≥ 80% agreement in two rounds of voting were included. Final recommendations reflect expert consensus and current best evidence.
Results: A total of 58 consensus statements were adopted. Key recommendations address clinical diagnosis on the basis of lesion type and anatomical location, the use of Hurley staging and International Hidradenitis Suppurativa Severity Score System (IHS4) for severity assessment, and the need for screening for metabolic and inflammatory comorbidities. Treatment guidance includes lifestyle modifications, the use of topical and systemic antibiotics, hormonal therapy, biologics and surgical options, based on disease severity. Supportive…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.